Response to Induction Chemotherapy Predicts Survival in AML: A Single Centre Experience from North India
Journal Title: Indian Journal of Cancer Education and Research - Year 2018, Vol 6, Issue 2
Abstract
Aim: The present study was carried out to analyze the various patient related (e.g. age, sex, performance status), disease related (white blood cell count, cytogenetic and molecular mutational status)and treatment related (delay in treatment initiation and response to induction chemotherapy)variables as predictors of outcome in acute myeloid leukemia (AML) patients presenting to a tertiary care center in North India. Materials and Methods: Thedata of all newly diagnosed de-novo AML patients who presented to our center from January 2015 to December 2017 and opted for chemotherapy was correlated with treatment outcome. Results: Sixty eight patients underwent induction chemotherapy during the study period. Sixteen (23.5%), 49 (72.1%) and 3 (4.4%) were in the favorable, intermediate and adverse risk groups, respectively. Fifteen (22%), 8 (11.7%) and 11 (16.1%) patients were positive for AML-ETO, NPM1, FLT3 mutations (3 patients had FLT3 D835 mutations), respectively. Exon 17 c-kit mutations were seen in 10 (14.7%) patients. We did not observe any exon 8 c-kit mutations in our cohort of patients. Biallelic CEBPA mutations were seen in 6 patients (8.8%). Following induction chemotherapy, 26 (38.2%) patients attained complete remission (CR), 20 (29.4%) achieved incomplete CR (platelet count<100 x 109/L) and 22 (32.4%) were refractory to induction therapy. There were only 3 (4.4%) induction deaths.High TLC was associated with FLT3 mutations (p=0.03) and presence of extra medullary disease correlated with AML-ETO (p=0.02) and c-KIT mutations (p=0.02). There was statistically significant correlation of FLT3-ITD mutation positive patients with risk of relapse (p= 0.001). The 2 yr Overall survival (OS) and Event free survival (EFS) were 39.6% and 22.8%, respectively. In a multivariate analysis, the performance status (PS) and post induction remission status independently predicted survival. Conclusion: Thus our data highlights that PS and post induction remission status translates into better OS.
Authors and Affiliations
Anshul Gupta
Keywords
Related Articles
- EP ID EP569258
- DOI 10.21088/ijcer.2321.9815.6218.2
- Views 79
- Downloads 0
Malignant Melanoma of Anorectum with Liver Metastasis: A Case Report
Anal melanoma is an uncommon and very aggressive cancer. Different surgical techniques have been used to manage this disease with no clear favour of one approach over the another. We saw one patient with a mass in anal r...
Role of Image Guided Radiotherapy (IGRT) in Patients Treated with Intensity Modulated Radiotherapy (IMRT) & Volumetric Modulated Arc Therapy (VMAT) in Head and Neck and Pelvic Cancers
Background: IGRT is the latest development for increasing the precision and accuracy in radiation therapy. Usage of specialized multi professional teams for coordinating geometric verification and use of clearly defined...
Sebaceous Gland Carcinoma of Upper Eyelid with Parotid Metastasis: A Case Report
Sebaceous gland carcinoma is a rare malignancy which usually arises from periocular region. It accounts of 1–5.5% eyelid malignancies and represents third most common eyelid malignancy. It mostly occurs in elderly women...
Induction Chemotherapy in Unresectable or Locally Advanced Head and Neck Squamous Cell Cancer: A Single Center Retrospective Experience
Head and Neck Squamous Cell Carcinoma (HNSCC), have an unsatisfactory prognosis despite intensive local treatment. Single institution retrospective study of 60 patients, who were treated with induction chemotherapy follo...
Colorectal Cancer Incidence in Tertiary Health Care Centre-Hyderabad
Background: Colorectal cancer (CRC) is the fourth most common cancer in the world. Its incidence varies worldwide being high in western countries and in older age group and low in developing countries. Though relatively...